Canada · Delayed Price · Currency is CAD Medicenna Therapeutics Statistics
Total Valuation
TSX:MDNA has a market cap or net worth of CAD 76.75 million. The enterprise value is 61.15 million.
| Market Cap | 76.75M |
| Enterprise Value | 61.15M |
Important Dates
The next estimated earnings date is Tuesday, February 10, 2026.
| Earnings Date | Feb 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:MDNA has 83.42 million shares outstanding. The number of shares has increased by 11.18% in one year.
| Current Share Class | 83.42M |
| Shares Outstanding | 83.42M |
| Shares Change (YoY) | +11.18% |
| Shares Change (QoQ) | +1.07% |
| Owned by Insiders (%) | 14.40% |
| Owned by Institutions (%) | n/a |
| Float | 60.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 7.49 |
| P/TBV Ratio | 7.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.43 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.01, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.01 |
| Quick Ratio | 3.81 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -91.21% and return on invested capital (ROIC) is -89.07%.
| Return on Equity (ROE) | -91.21% |
| Return on Assets (ROA) | -53.51% |
| Return on Invested Capital (ROIC) | -89.07% |
| Return on Capital Employed (ROCE) | -160.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -767,500 |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.78% in the last 52 weeks. The beta is 1.87, so TSX:MDNA's price volatility has been higher than the market average.
| Beta (5Y) | 1.87 |
| 52-Week Price Change | -28.78% |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | 1.07 |
| Relative Strength Index (RSI) | 46.10 |
| Average Volume (20 Days) | 132,783 |
Short Selling Information
The latest short interest is 222,810, so 0.29% of the outstanding shares have been sold short.
| Short Interest | 222,810 |
| Short Previous Month | 150,128 |
| Short % of Shares Out | 0.29% |
| Short % of Float | 0.45% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -21.82M |
| Pretax Income | -13.82M |
| Net Income | -13.82M |
| EBITDA | -21.80M |
| EBIT | -21.82M |
| Earnings Per Share (EPS) | -0.17 |
Balance Sheet
The company has 15.75 million in cash and 149,000 in debt, with a net cash position of 15.60 million or 0.19 per share.
| Cash & Cash Equivalents | 15.75M |
| Total Debt | 149,000 |
| Net Cash | 15.60M |
| Net Cash Per Share | 0.19 |
| Equity (Book Value) | 10.24M |
| Book Value Per Share | 0.12 |
| Working Capital | 13.41M |
Cash Flow
| Operating Cash Flow | -17.03M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:MDNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.18% |
| Shareholder Yield | -11.18% |
| Earnings Yield | -18.00% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 3, 2017. It was a reverse split with a ratio of 0.0714285.
| Last Split Date | Mar 3, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.0714285 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |